Trademark: 98235302
Status Date
Thursday, October 26, 2023
Filing Date
Monday, October 23, 2023
44 Liquid biopsy testing for cancer cells using predictive markers and signatures directed to exome and transcriptome molecular profiling and biopsy testing assays using circulating nucleic acids sequencing (cNAS) for analysis of Whole Exome (cfDNA) and Whole Transcriptome (cfRNA) genes
Mar 12, 2024
Amendment To Use Processing Complete
Mar 12, 2024
Use Amendment Filed
Mar 12, 2024
Teas Amendment Of Use Received
Oct 26, 2023
New Application Office Supplied Data Entered
Oct 26, 2023
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24